Xylem price target raised to $172 from $165 at Barclays

Barclays analyst William Grippin raised the firm’s price target on Xylem (XYL) to $172 from $165 and keeps an Overweight rating on the shares following the earnings report. The company’s business optimization efforts drove better than anticipated margin progression, the analyst tells investors in a research note.